26. HTLV-1関連脊髄症 HTLV-1-associated myelopathy Clinical trials / Disease details

臨床試験数 : 28 / 薬物数 : 48 - (DrugBank : 28) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 127

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04301076 (ClinicalTrials.gov)	June 15, 2020	6/3/2020	Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Tre ...	A Phase 1 Study of Lenalidomidein Combination With EPOCH Chemotherapy for HTLV-Associated Adult T-Ce ...	Acute Adult T-Cell Leukemia/Lymphoma;Adult T-Cell Leukemia/Lymphoma;Chronic Adult T-Cell Leukemia/Ly ...	Drug: Cyclophosphamide;Drug: Doxorubicin Hydrochloride;Drug: Etoposide;Drug: Lenalidomide;Drug: Predn ...	National Cancer Institute (NCI)	NULL	Recruiting	18 Years	N/A	All	30	Phase 1	United States
2	NCT01274533 (ClinicalTrials.gov)	December 2010	10/1/2011	Lenalidomide in HTLV-1 Adult T-Cell Leukemia	A Phase II Study of Lenalidomidein Patients With Relapsed or Refractory HTLV-1 Associated Adult T Ce ...	Adult T Cell Leukemia/Lymphoma	Drug: Lenalidomide	Columbia University	Celgene Corporation	Completed	18 Years	N/A	All	4	Phase 2	United States

First Previous1Next Last